Ifenprodil Tartrate

酒石酸艾芬地尔

Report date: 2023/03/31 17:34:31
NME

Base Information

Drug NameIfenprodil Tartrate
Drug Alias NameIfenprodilum酒石酸艾芬罗地CerocralVadilexRC-61-91
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdrenergic receptors antagonistsGlutamate [NMDA] receptor antagonists
TargetsAdrenergic receptorsGlutamate [NMDA] receptor
Therapy Area/IndicationsStress Disorders, Post-TraumaticDizziness
Global Approved IndicationsDizziness
Approved Indications in ChinaN/A
Original Approved Country/TerritoryJapan
Original Approved Date1971/01/01
Country/TerritoryJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesSanofi
China Registration ClassN/A

Develop Information

Active CompaniesSanofi Kk
Inactive CompaniesChiba University
Active IndicationsDizziness
Inactive IndicationsStress Disorders, Post-Traumatic

Other Information

ATC CodeC04AX28
Related LinksWikipediaDrugBankKEGG